Hexamethylene bisacetamide Inhibitor

MBS5758726 is an inhibitor targeting Hexamethylene bisacetamide. Hexamethylene bisacetamide inhibits BET Bromodomain Proteins.

Nilsson L M, Green L C, Muralidharan S V, et al. Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain Proteins[J]. Cancer Research, 2016, 76(8):2376.
Nilsson L M, Green L C, Muralidharan S V, et al. Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain Proteins[J]. Cancer Research, 2016, 76(8):2376.
Marks P A, Rifkind R A. Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.[J]. Environmental Health Perspectives, 1989, 80:181-188.
Marks P A, Rifkind R A. Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.[J]. Environmental Health Perspectives, 1989, 80:181-188.

Small volumes of Hexamethylene bisacetamide, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.